ICSNT Primer for the Skull Base Community: Navigating the Landscape of Sinonasal Tumors with Synthesized Literature Guidance
Edward C. Kuan,Eric W. Wang,Nithin D. Adappa,Daniel M. Beswick,Adam L. Holtzman,Nyall R. London,Timothy L. Smith,Shirley Y. Su,Marilene B. Wang,James N. Palmer
DOI: https://doi.org/10.1055/s-0044-1787155
2024-05-24
Journal of Neurological Surgery Part B Skull Base
Abstract:The growing recognition of the intricate challenges of skull base pathologies has spurred an unprecedented collaborative effort among multidisciplinary teams, both clinically and academically. A central concern within the skull base community revolves around the management of sinonasal tumors, given the predilection of these tumors to involve the anterior skull base. Despite intense interest, synthesis of the expanding evidence in sinonasal oncology is lacking. In response to this, the International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors (ICSNT) was developed, serving as a comprehensive, up-to-date, and "one stop shop" compendium housing the best available evidence in sinonasal oncology.[1] The ICSNT project was undertaken with several key missions in mind: to be (1) histopathology-driven; (2) international and diverse; (3) multidisciplinary; (4) comprehensive; (5) embody a collaborative spirit much like to model of care for oncologic and skull base patients; and (6) serve as a reference for the current state of the evidence but not as clinical guidelines. Much of the ICSNT content has built upon work from a prior consensus document, the International Consensus Statement on Endoscopic Skull-Base Surgery (ICSB),[2] and ICSNT was designed to be complementary and cross-referenced to the ICSB for areas of overlap. A total of 48 author "teams" (189 total authors spanning 20 countries) were invited to author the document and were selected based upon publication record and academic focus in sinonasal oncology; specifically, invited authors assembled a multidisciplinary team of collaborators and colleagues to co-write each section. The format is structured akin to a large-scale systematic review utilizing Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Authors were intentionally instructed to summarize the literature and avoid editorializing or interjecting individual preferences and biases. Each section underwent an iterative review process by four members of the editorial leadership, and consensus was achieved following a 1-month open review period. For those sections with the highest levels of evidence, the aggregate grade of evidence (AGE) and recommendations were reported based on American Academy of Pediatrics Steering Committee on Quality Improvement and Management guidelines.[3] Of note, ICSNT focuses primarily on those diseases which originate within the sinonasal tract, and does not cover intracranial neoplasms or surgical techniques; rather, it aims to bring clarity to diagnostic, management, and prognostic decisions. ICSNT is divided into four sections—General Principles; Benign Lesions/Neoplasms; Malignant Neoplasms; and Morbidity, QOL, and Surveillance. The General Principles section covers critical concepts that are relevant to the skull base community when considering treatment of sinonasal tumors, including both surgical and nonsurgical (i.e., radiation) modalities ([Table 1]). The focus of the Benign Lesions/Neoplasms section is largely on the most predominant conditions, including inverted papillomas, juvenile nasopharyngeal angiofibroma, and intraconal orbital lesions ([Table 2]). The vast majority of the content is found in the Malignant Neoplasms section, which systematically analyzes each distinct histopathologic condition and examines the evidence surrounding evaluation, treatment, and outcomes ([Table 3]). The final section provides an overview of long-term care, such as tumor surveillance, treatment morbidity, assessment of quality of life, and complications. Broad topic Intervention Recommendation AGE Principles of surgical treatment The decision for en bloc versus piecemeal resection is based on tumor extension and sites of involvement Option C En bloc resection of the site of attachment should be attempted whenever possible Recommendation C Workup of regional and distant disease Combination of exam, endoscopy, and CT/MRI remains gold standard; PET is option Recommendation C Surgical approach For most tumors, recommend endoscopic approach first line for lower stage lesions Endoscopic approach is an option for higher stage lesions Depends on resectability and tumor biology Recommendation for EEA for low-stage tumors Option for EEA for high-stage tumors C For maxillary sinus lesions, recommend endoscopic approach first line for benign lesions Endoscopic approach is an option for malignant lesions Assess soft tissue involvement Recommendation for EEA for IP and other benign lesions Option for EEA for malignant tumors based upon anatomical involvement and at the discretion and comfort of the surgeon C Margin analysis If surgical treatment for curative intent is elected, the goal should be to obtain negative margins whenever feasible, not GTR Consider using frozen sections to guide resection Nuances based on tumor type (e.g., ACC where GTR may be cons -Abstract Truncated-
surgery,clinical neurology